Retracting Statement, ABI Will Not Seek EU, US Regulatory Approval for Avian Disease Assays | GenomeWeb
NEW YORK (GenomeWeb News) — Applied Biosystems today retracted statements made by a spokesman yesterday that the company plans to file certain pathogen-detecting assay kits with US and European regulators.
 
As GenomeWeb News reported on yesterday, ABI said it plans to develop and market pathogen-detecting assay kits through a collaboration with the UK government’s Veterinary Laboratories Agency.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.